These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 21440529
1. ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression. Park S, Jung HH, Park YH, Ahn JS, Im YH. Biochem Biophys Res Commun; 2011 Apr 22; 407(4):680-6. PubMed ID: 21440529 [Abstract] [Full Text] [Related]
2. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells. Said AH, Hu S, Abutaleb A, Watkins T, Cheng K, Chahdi A, Kuppusamy P, Saxena N, Xie G, Raufman JP. Biochem J; 2017 Feb 20; 474(5):647-665. PubMed ID: 28008134 [Abstract] [Full Text] [Related]
3. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors. Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG. Cancer Res; 2004 Jul 01; 64(13):4637-47. PubMed ID: 15231676 [Abstract] [Full Text] [Related]
5. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. Qiu Q, Yang M, Tsang BK, Gruslin A. Reproduction; 2004 Sep 01; 128(3):355-63. PubMed ID: 15333786 [Abstract] [Full Text] [Related]
7. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells. Li CC, Yao HT, Cheng FJ, Hsieh YH, Lu CY, Wu CC, Liu KL, Chang JW. Nutr Cancer; 2015 Sep 01; 67(5):771-82. PubMed ID: 25970488 [Abstract] [Full Text] [Related]
8. Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells. Kim S, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE. Anticancer Res; 2011 Nov 01; 31(11):3767-73. PubMed ID: 22110198 [Abstract] [Full Text] [Related]
9. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y, Li X, Jiang J, Frank SJ. Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991 [Abstract] [Full Text] [Related]
10. Additive effects of EGF and IL-1β regulate tumor cell migration and invasion in gastric adenocarcinoma via activation of ERK1/2. Han J, Xie Y, Lan F, Yu Y, Liu W, Chen J, Zheng F, Ouyang X, Lin X, Lin Y, Huang Q, Wang L, Tan J. Int J Oncol; 2014 Jul 07; 45(1):291-301. PubMed ID: 24789460 [Abstract] [Full Text] [Related]
11. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Li B, Chang CM, Yuan M, McKenna WG, Shu HK. Cancer Res; 2003 Nov 01; 63(21):7443-50. PubMed ID: 14612544 [Abstract] [Full Text] [Related]
12. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity. Cardoso AP, Pinto ML, Pinto AT, Oliveira MI, Pinto MT, Gonçalves R, Relvas JB, Figueiredo C, Seruca R, Mantovani A, Mareel M, Barbosa MA, Oliveira MJ. Oncogene; 2014 Apr 17; 33(16):2123-33. PubMed ID: 23644655 [Abstract] [Full Text] [Related]
13. EGFR phosphorylation-dependent formation of cell-cell contacts by Ras/Erks cascade inhibition. Kang ES, Oh MA, Lee SA, Kim TY, Kim SH, Gotoh N, Kim YN, Lee JW. Biochim Biophys Acta; 2007 Jun 17; 1773(6):833-43. PubMed ID: 17368581 [Abstract] [Full Text] [Related]
14. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS. Stem Cells Dev; 2008 Aug 17; 17(4):725-36. PubMed ID: 18788932 [Abstract] [Full Text] [Related]
15. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival. Ripple MO, Kalmadi S, Eastman A. Breast Cancer Res Treat; 2005 Sep 17; 93(2):177-88. PubMed ID: 16187238 [Abstract] [Full Text] [Related]
16. The EGF receptor-sox2-EGF receptor feedback loop positively regulates the self-renewal of neural precursor cells. Hu Q, Zhang L, Wen J, Wang S, Li M, Feng R, Yang X, Li L. Stem Cells; 2010 Feb 17; 28(2):279-86. PubMed ID: 19882665 [Abstract] [Full Text] [Related]
17. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts. Bujor AM, Nakerakanti S, Morris E, Hant FN, Trojanowska M. Exp Dermatol; 2010 Apr 17; 19(4):347-54. PubMed ID: 20201953 [Abstract] [Full Text] [Related]
18. [EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells]. Guo YH, Gao FH, Shi J, Yuan HH, Jiang B. Zhonghua Zhong Liu Za Zhi; 2013 Mar 17; 35(3):187-92. PubMed ID: 23879998 [Abstract] [Full Text] [Related]
19. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines. Dizeyi N, Hedlund P, Bjartell A, Tinzl M, Austild-Taskén K, Abrahamsson PA. Urol Oncol; 2011 Mar 17; 29(4):436-45. PubMed ID: 19926313 [Abstract] [Full Text] [Related]
20. Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase. Perlman A, Lawsin LM, Kolachana P, Saji M, Moore J, Ringel MD. Ann Clin Lab Sci; 2004 Mar 17; 34(3):277-86. PubMed ID: 15487702 [Abstract] [Full Text] [Related] Page: [Next] [New Search]